Century Therapeutics (IPSC) Other Non-Current Assets (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Other Non-Current Assets of $2.7 million for Q1 2026, down 2.38% year-over-year from $2.8 million in Q1 2025, and down 14.22% quarter-over-quarter from $3.2 million in Q4 2025.
Century Therapeutics (IPSC) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Other Non-Current Assets for 7 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 2.38% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (down 2.38% YoY), while the FY2025 annual figure was $3.2 million, up 13.92% from the prior year.
- Other Non-Current Assets slipped to $2.7 million in Q1 2026 per IPSC's latest filing, from $3.2 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.2 million in Q3 2025 and bottomed at $563000.0 in Q3 2023.
- Historically, Other Non-Current Assets has averaged $2.1 million across 5 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 55.95% — and 2025, when it surged 459.12%.
- Century Therapeutics' Other Non-Current Assets stood at $1.3 million in 2022, then surged by 57.06% to $2.0 million in 2023, then jumped by 40.07% to $2.8 million in 2024, then advanced by 13.92% to $3.2 million in 2025, then declined by 14.22% to $2.7 million in 2026.
- Business Quant data shows IPSC's Other Non-Current Assets at $2.7 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 2.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.36 Mn |
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 563,000.00 |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.72 Mn |